Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis
暂无分享,去创建一个
Yoshihide Fujiyama | Y. Benno | K. Mitsuyama | A. Andoh | Y. Fujiyama | Akira Andoh | Shinji Sakata | Yuhsuke Koizumi | Keiichi Mitsuyama | Yoshimi Benno | S. Sakata | Y. Koizumi
[1] C. Cerniglia,et al. PCR detection of Ruminococcus spp. in human and animal faecal samples. , 1997, Molecular and cellular probes.
[2] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[3] S. Cucchiara,et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.
[4] P. Saxman,et al. Terminal Restriction Fragment Length Polymorphism Analysis Program, a Web-Based Research Tool for Microbial Community Analysis , 2000, Applied and Environmental Microbiology.
[5] M. Wilkinson,et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples , 1995, Applied and environmental microbiology.
[6] H. Hayashi,et al. Molecular Analysis of Fecal Microbiota in Elderly Individuals Using 16S rDNA Library and T‐RFLP , 2003, Microbiology and immunology.
[7] J. Doré,et al. Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd , 2005, Inflammatory bowel diseases.
[8] F. Shanahan,et al. Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice , 2001, Alimentary pharmacology & therapeutics.
[9] Joël Doré,et al. Gut flora and inflammatory bowel disease , 2004 .
[10] S. Miehlke,et al. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. , 2006, Journal of medical microbiology.
[11] M. Sakamoto,et al. Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis. , 2003, Journal of medical microbiology.
[12] Manfred Dietel,et al. Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.
[13] Philippe Marteau,et al. Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[14] J. Doré,et al. Review article: gut flora and inflammatory bowel disease. , 2004, Alimentary pharmacology & therapeutics.
[15] C. Neut,et al. Self inflicted rectal ulcer: hearing is believing , 2003, Gut.
[16] J. Doré,et al. Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut , 1999, Applied and Environmental Microbiology.
[17] D. Rampton,et al. Molecular Characterization of Rectal Mucosa‐Associated Bacterial Flora in Inflammatory Bowel Disease , 2005, Inflammatory bowel diseases.
[18] C. Kitts,et al. Terminal restriction fragment patterns: a tool for comparing microbial communities and assessing community dynamics. , 2001, Current issues in intestinal microbiology.
[19] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[20] A. Andoh,et al. Characterization of antibody responses against rectal mucosa‐associated bacterial flora in patients with ulcerative colitis , 2000, Journal of gastroenterology and hepatology.
[21] E. Zoetendal,et al. Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria , 1998, Applied and Environmental Microbiology.
[22] D. Karl,et al. A computer-simulated restriction fragment length polymorphism analysis of bacterial small-subunit rRNA genes: efficacy of selected tetrameric restriction enzymes for studies of microbial diversity in nature , 1996, Applied and environmental microbiology.
[23] Ami,et al. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.
[24] R. Hammer,et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.
[25] H. Hayashi,et al. Terminal Restriction Fragment Length Polymorphism Analysis for Human Fecal Microbiota and Its Application for Analysis of Complex Bifidobacterial Communities , 2003, Microbiology and immunology.
[26] H. Hayashi,et al. Diversity of the Clostridium coccoides group in human fecal microbiota as determined by 16S rRNA gene library. , 2006, FEMS microbiology letters.
[27] Y. Mahida,et al. Host-bacterial interactions in inflammatory bowel disease. , 2004, Clinical science.
[28] R. Bibiloni,et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. , 2006, Journal of medical microbiology.
[29] K. Nagashima,et al. Application of New Primer-Enzyme Combinations to Terminal Restriction Fragment Length Polymorphism Profiling of Bacterial Populations in Human Feces , 2003, Applied and Environmental Microbiology.
[30] H. Kiyono,et al. Alteration of Vβ Usage and Cytokine Production of CD4+ TCR ββ Homodimer T Cells by Elimination of Bacteroides vulgatus Prevents Colitis in TCR α-Chain-Deficient Mice1 , 2000, The Journal of Immunology.
[31] Gerwin C. Raangs,et al. Variations of Bacterial Populations in Human Feces Measured by Fluorescent In Situ Hybridization with Group-Specific 16S rRNA-Targeted Oligonucleotide Probes , 1998, Applied and Environmental Microbiology.
[32] J. Hampe,et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.
[33] H. Kiyono,et al. Alteration of V beta usage and cytokine production of CD4+ TCR beta beta homodimer T cells by elimination of Bacteroides vulgatus prevents colitis in TCR alpha-chain-deficient mice. , 2000, Journal of immunology.
[34] D. Jewell,et al. Role of the faecal stream in the maintenance of Crohn's colitis. , 1985, Gut.
[35] E. Zoetendal,et al. Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces , 2002, Applied and Environmental Microbiology.
[36] R Balfour Sartor,et al. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.
[37] Mitsuo Sakamoto,et al. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. , 2005, Journal of medical microbiology.
[38] H. Hayashi,et al. Phylogenetic Analysis of the Human Gut Microbiota Using 16S rDNA Clone Libraries and Strictly Anaerobic Culture‐Based Methods , 2002, Microbiology and immunology.
[39] Mitsuo Sakamoto,et al. Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. , 2005, Journal of microbiological methods.